Robert S. Call

3.6k total citations · 1 hit paper
22 papers, 1.2k citations indexed

About

Robert S. Call is a scholar working on Dermatology, Physiology and Immunology and Allergy. According to data from OpenAlex, Robert S. Call has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Dermatology, 12 papers in Physiology and 12 papers in Immunology and Allergy. Recurrent topics in Robert S. Call's work include Dermatology and Skin Diseases (16 papers), Asthma and respiratory diseases (12 papers) and Allergic Rhinitis and Sensitization (10 papers). Robert S. Call is often cited by papers focused on Dermatology and Skin Diseases (16 papers), Asthma and respiratory diseases (12 papers) and Allergic Rhinitis and Sensitization (10 papers). Robert S. Call collaborates with scholars based in United States, Canada and Austria. Robert S. Call's co-authors include Thomas A.E. Platts‐Mills, Martin D. Chapman, Elsie C. Morris, Thomas F. Smith, Adelaide A. Hebert, Lee T. Zane, Lawrence F. Eichenfield, Douglass W. Forsha, Mary Spellman and Linda Stein Gold and has published in prestigious journals such as The Journal of Immunology, PEDIATRICS and Journal of Allergy and Clinical Immunology.

In The Last Decade

Robert S. Call

22 papers receiving 1.1k citations

Hit Papers

Efficacy and safety of crisaborole ointment, a novel, non... 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
    2016 415 citations Amy S. Paller, Wynnis L. Tom et al. Journal of the American Academy of Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert S. Call United States 9 808 625 535 182 112 22 1.2k
Esben Eller Denmark 17 832 1.0× 463 0.7× 408 0.8× 57 0.3× 133 1.2× 36 1.1k
Hugo Van Bever Singapore 15 290 0.4× 212 0.3× 302 0.6× 31 0.2× 102 0.9× 33 622
Edyta Krzych‐Fałta Poland 16 371 0.5× 201 0.3× 309 0.6× 41 0.2× 74 0.7× 92 632
Richard W. Honsinger United States 8 516 0.6× 95 0.2× 516 1.0× 207 1.1× 112 1.0× 12 724
Anna Asarnoj Sweden 15 735 0.9× 276 0.4× 395 0.7× 24 0.1× 88 0.8× 27 868
John Beschorner Germany 7 530 0.7× 163 0.3× 369 0.7× 23 0.1× 135 1.2× 8 698
A I Manjra South Africa 14 379 0.5× 312 0.5× 647 1.2× 23 0.1× 518 4.6× 35 1.0k
Kirsty Logan United Kingdom 17 902 1.1× 373 0.6× 428 0.8× 18 0.1× 72 0.6× 29 1.3k
Roy Gerth van Wijk Netherlands 3 1.1k 1.4× 345 0.6× 1.1k 2.0× 22 0.1× 248 2.2× 5 1.3k
Gil‐Soon Choi South Korea 16 318 0.4× 196 0.3× 395 0.7× 45 0.2× 201 1.8× 73 879

Countries citing papers authored by Robert S. Call

Since Specialization
Citations

This map shows the geographic impact of Robert S. Call's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Call with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Call more than expected).

Fields of papers citing papers by Robert S. Call

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Call. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Call. The network helps show where Robert S. Call may publish in the future.

Co-authorship network of co-authors of Robert S. Call

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Call. A scholar is included among the top collaborators of Robert S. Call based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Call. Robert S. Call is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bissonnette, Robert, Robert S. Call, Zhaoyin Zhu, et al.. (2022). A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis. American Journal of Clinical Dermatology. 23(3). 355–364. 32 indexed citations
2.
3.
Paller, Amy S., Gil Yosipovitch, Wynnis L. Tom, et al.. (2018). Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials. PEDIATRICS. 142(1_MeetingAbstract). 814–814. 1 indexed citations
4.
Eichenfield, Lawrence F., Robert S. Call, Douglass W. Forsha, et al.. (2017). Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis. Journal of the American Academy of Dermatology. 77(4). 641–649.e5. 109 indexed citations
5.
Zane, Lee T., Leon Kircik, Robert S. Call, et al.. (2016). Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open‐Label, Maximal‐Use Systemic Exposure Study. Pediatric Dermatology. 33(4). 380–387. 61 indexed citations
6.
Paller, Amy S., Wynnis L. Tom, Robert S. Call, et al.. (2016). 286 Phase 3 studies in atopic dermatitis with the novel, nonsteroidal topical phosphodiesterase 4 inhibitor, crisaborole. Journal of Investigative Dermatology. 136(5). S50–S50. 3 indexed citations
7.
Paller, Amy S., Wynnis L. Tom, Robert S. Call, et al.. (2016). 033 A novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase inhibitor, Crisaborole Topical Ointment, 2%, in two phase 3 studies in children and adults with mild to moderate atopic dermatitis. Journal of Investigative Dermatology. 136(9). S166–S166. 3 indexed citations
8.
Paller, Amy S., Wynnis L. Tom, Mark Lebwohl, et al.. (2016). Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. Journal of the American Academy of Dermatology. 75(3). 494–503.e6. 415 indexed citations breakdown →
9.
Eichenfield, Lawrence F., Robert S. Call, Douglass W. Forsha, et al.. (2016). 280 Long-term safety of crisaborole topical ointment, 2%, in atopic dermatitis. Journal of Investigative Dermatology. 136(5). S49–S49. 1 indexed citations
10.
Zane, Lee T., Lawrence F. Eichenfield, Robert S. Call, et al.. (2016). Long-term safety of Crisaborole Topical Ointment, 2%, in children and adults with mild- to-moderate atopic dermatitis. The Journal of Immunology. 196(1_Supplement). 191.28–191.28. 3 indexed citations
11.
Boguniewicz, Mark, Amy S. Paller, Wynnis L. Tom, et al.. (2016). Efficacy and Safety of Crisaborole Topical Ointment, 2%, a Novel, Nonsteroidal, Topical, Anti-Inflammatory, Phosphodiesterase Inhibitor in 2 Phase 3 Studies in Children and Adults with Mild-to-Moderate Atopic Dermatitis. Journal of Allergy and Clinical Immunology. 137(2). AB397–AB397. 3 indexed citations
12.
Paller, Amy S., Wynnis L. Tom, Mark Lebwohl, et al.. (2016). Two phase 3 studies in atopic dermatitis with crisaborole, the novel, nonsteroidal topical phosphodiesterase 4 inhibitor. 33. 2 indexed citations
13.
Eichenfield, Lawrence F., Robert S. Call, Douglass W. Forsha, et al.. (2016). Long-term safety of crisaborole in children and adults with mild-to-moderate atopic dermatitis. 33. 2 indexed citations
14.
Kircik, Leon, Robert S. Call, Eduardo Tschen, et al.. (2015). Maximal use systemic exposure study evaluating AN2728, a novel boron-based small molecule, for the treatment of pediatric and adolescent subjects with mild-to-moderate atopic dermatitis (THER2P.959). The Journal of Immunology. 194(1_Supplement). 67.10–67.10. 3 indexed citations
15.
Patel, Piyush M., George Philip, William H. Yang, et al.. (2005). Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Annals of Allergy Asthma & Immunology. 95(6). 551–557. 61 indexed citations
16.
Perzanowski, Matthew S., Richard Sporik, Susan Pollart Squillace, et al.. (1998). Association of sensitization to Alternaria allergens with asthma among school-age children. Journal of Allergy and Clinical Immunology. 101(5). 626–632. 87 indexed citations
17.
Hayden, Mary Lou, et al.. (1997). Dust Mite Allergen Avoidance in the Treatment of Hospitalized Children with Asthma. Annals of Allergy Asthma & Immunology. 79(5). 437–442. 18 indexed citations
18.
Hayden, Mary Lou, et al.. (1996). 167 Effect of dst mite allergen avoidance in homes of children hospitalized with acute asthma. Journal of Allergy and Clinical Immunology. 97(1). 224–224. 1 indexed citations
19.
Call, Robert S., et al.. (1994). Investigating severe and fatal asthma. Journal of Allergy and Clinical Immunology. 94(6). 1065–1072. 28 indexed citations
20.
Call, Robert S., Thomas F. Smith, Elsie C. Morris, Martin D. Chapman, & Thomas A.E. Platts‐Mills. (1992). Risk factors for asthma in inner city children. The Journal of Pediatrics. 121(6). 862–866. 321 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esben Eller Breakdown of academic impact, for papers by Hugo Van Bever Breakdown of academic impact, for papers by Edyta Krzych‐Fałta Breakdown of academic impact, for papers by Richard W. Honsinger Breakdown of academic impact, for papers by Anna Asarnoj Breakdown of academic impact, for papers by John Beschorner Breakdown of academic impact, for papers by A I Manjra Breakdown of academic impact, for papers by Kirsty Logan Breakdown of academic impact, for papers by Roy Gerth van Wijk Breakdown of academic impact, for papers by Gil‐Soon Choi
Rankless by CCL
2026